DaVita
DVA
#2038
Rank
HK$78.14 B
Marketcap
HK$1,169
Share price
1.52%
Change (1 day)
-3.01%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$78.92

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$79.09. In 2024 the company made an earnings per share (EPS) of HK$86.20 an increase over its 2023 EPS that were of HK$59.47.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$78.92-8.44%
2024HK$86.2044.94%
2023HK$59.4727.26%
2022HK$46.73-35.56%
2021HK$72.5244.1%
2020HK$50.3319.7%
2019HK$42.05540.48%
2018HK$6.56-76.07%
2017HK$27.43-19.31%
2016HK$34.00242.52%
2015HK$9.93-62.87%
2014HK$26.7313.43%
2013HK$23.568.45%
2012HK$21.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$166.85 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$80.11 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$114.88 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.84-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA